Parallax Volatility Advisers, L.P. Repligen Corp Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $617,163 - $824,843	4,387 Added 68.92%	10,752 $1.75 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $1.03 Million - $1.64 Million	6,365 New	6,365 $1.2 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $2,620 - $3,328	-53 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $2,557 - $3,650	53 New	53 $3,000
Q1 2018 May 15, 2018	SELL	$30.92 - $37.27 $176,615 - $212,886	-5,712 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $185,811 - $222,311	5,712	5,712 $207,000

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.